Compounds > lamivudine
Page last updated: 2024-08-24

lamivudine and Delayed Hypersensitivity

lamivudine has been researched along with Delayed Hypersensitivity in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (60.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiozzi, MH; Connick, E; Fox, L; Kessler, H; Kotzin, BL; Kuritzkes, DR; Landay, A; Lederman, MM; Leonard, JM; Martinez, A; Roe, JD; Rousseau, F; Spritzler, J; St Clair, M; Wade, M1
Boyle, B; Corral, LG; Elbeik, T; Haslett, PA; Kaplan, G; Klausner, JD; Kunachiwa, W; Makonkawkeyoon, S; Maneekarn, N; Metatratip, P; Moreira, A; Shen, Z; Vongchan, P1
Bricalli, D; Clerici, M; Dally, L; Pirillo, M; Principi, N; Sala, N; Saresella, M; Trabattoni, D; Vella, S; Viganò, A1
Chiozzi, MH; Connick, E; D'Arc Roe, J; Fox, L; Kessler, H; Kotzin, BL; Kuritzkes, DR; Landay, A; Lederman, MM; Leonard, JM; Martinez, A; Rousseau, F; Sevin, AD; Spritzler, J; St Clair, M1
Connick, E; Evans, TG; Fox, L; Heath-Chiozzi, M; Kessler, H; Kuritzkes, DR; Landay, A; Lederman, HM; Lederman, MB; Lederman, MM; Roe, J; Smith, KY; Spritzler, J; Valdez, H1

Trials

4 trial(s) available for lamivudine and Delayed Hypersensitivity

ArticleYear
Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315.
    The Journal of infectious diseases, 1998, Volume: 178, Issue:1

    Topics: Adult; Anti-HIV Agents; Antigens; B-Lymphocytes; CD4 Lymphocyte Count; Drug Therapy, Combination; Female; HIV Antigens; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Hypersensitivity, Delayed; Lamivudine; Lymphocyte Activation; Lymphocyte Count; Male; Middle Aged; Reverse Transcriptase Inhibitors; Ritonavir; RNA, Viral; T-Lymphocyte Subsets; Time Factors; Zidovudine

1998
Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients.
    AIDS research and human retroviruses, 1999, Sep-01, Volume: 15, Issue:13

    Topics: Adult; Anti-HIV Agents; Cytokines; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Hypersensitivity, Delayed; Interleukin-2; Lamivudine; Lymphocyte Activation; Male; T-Lymphocytes; Thalidomide; Viral Load; Zidovudine

1999
Immune reconstitution in the first year of potent antiretroviral therapy and its relationship to virologic response.
    The Journal of infectious diseases, 2000, Volume: 181, Issue:1

    Topics: Anti-HIV Agents; Candida; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Drug Therapy, Combination; HIV Infections; Humans; Hypersensitivity, Delayed; Immune System; Lamivudine; Mumps virus; Ritonavir; RNA, Viral; Zidovudine

2000
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen. ACTG 375 team. AIDS Clinical Trials Group.
    AIDS (London, England), 2000, Jan-07, Volume: 14, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Therapy, Combination; Female; Hemocyanins; Hepatitis A Vaccines; HIV-1; Humans; Hypersensitivity, Delayed; Injections, Intradermal; Lamivudine; Male; Middle Aged; Ritonavir; T-Lymphocytes; Tetanus Toxoid; Thymus Gland; Vaccination; Viral Hepatitis Vaccines; Zidovudine

2000

Other Studies

1 other study(ies) available for lamivudine and Delayed Hypersensitivity

ArticleYear
Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection.
    The Journal of pediatrics, 1999, Volume: 135, Issue:6

    Topics: Adolescent; Anti-HIV Agents; CD4 Lymphocyte Count; Cell Division; Child; Drug Therapy, Combination; HIV Infections; Humans; Hypersensitivity, Delayed; Indinavir; Infectious Disease Transmission, Vertical; Lamivudine; Skin Tests; Stavudine; T-Lymphocytes; Treatment Outcome

1999